UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000000599 |
|---|---|
| Receipt number | R000000697 |
| Scientific Title | A phase II study of preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer |
| Date of disclosure of the study information | 2007/02/08 |
| Last modified on | 2019/08/22 16:45:31 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2007/02/07 17:07:47 | ||
| 2 | Update | 2008/02/11 18:25:25 | Last name of lead principal investigator Last name of lead principal investigator Email1 |
|
| 3 | Update | 2009/02/12 21:47:08 | Last name of lead principal investigator Last name of lead principal investigator |
|
| 4 | Update | 2019/08/19 09:07:12 | UMIN ID1 |
|
| 5 | Update | 2019/08/19 10:32:29 | UMIN ID2 UMIN ID3 |
|
| 6 | Update | 2019/08/22 16:02:56 | Classification by specialty |
|
| 7 | Update | 2019/08/22 16:12:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Address Address TEL Last name of contact person Last name of contact person Organization Organization Division name Division name Zip code Address Address TEL Name of person sending information Name of person sending information Organization Organization Division name Division name Address TEL Name of primary person or sponsor Institute Organization Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel |
|
| 8 | Update | 2019/08/22 16:37:47 | Recruitment status Date of IRB |
|
| 9 | Update | 2019/08/22 16:43:54 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 10 | Update | 2019/08/22 16:45:31 | Recruitment status |
